Acura Pharmaceuticals (OTCMKTS:ACUR) Share Price Passes Above 200-Day Moving Average – Time to Sell?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0005. Acura Pharmaceuticals shares last traded at $0.0005, with a volume of 200 shares trading hands.

Acura Pharmaceuticals Trading Down 75.0%

Acura Pharmaceuticals Company Profile

Acura Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing products designed to deter prescription drug abuse and misuse. The company’s core business centers on proprietary drug formulations that incorporate its Aversion and ARCUS® abuse-deterrent technologies. These platforms are intended to make it more difficult to tamper with or extract active pharmaceutical ingredients from oral dosage forms, helping to address public health concerns around opioid and stimulant abuse.

Acura’s lead product, Oxaydo®, is an immediate‐release oxycodone tablet that employs Aversion® technology to discourage tampering and intravenous abuse.